Eric A. Murphy
23Patents
4h-index
19Co-inventors
60Inventor score
Filing activity: Jun 18, 1998 → Feb 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6333179A | Methods and compositions for multiplex amplification of nucleic acids | Emerging Cross-Sectional Technologies | 20 | Expired |
| US11098031B1 | Inhibitors of RAF kinases | Chemistry; Metallurgy | 7 | Active |
| US10894788B2 | Inhibitors of cyclin-dependent kinases | Chemistry; Metallurgy | 6 | Active |
| US11377431B2 | Inhibitors of RAF kinases | Chemistry; Metallurgy | 5 | Active |
| US11407737B2 | Inhibitors of RAF kinases | Chemistry; Metallurgy | 4 | Active |
| US10806726B2 | Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors | Human Necessities | 3 | Active |
| US9212151B2 | Heterocyclic compounds useful for kinase inhibition | Chemistry; Metallurgy | 3 | Active |
| US8957216B2 | Heterocyclic compounds useful for kinase inhibition | Chemistry; Metallurgy | 2 | Active |
| US11684615B2 | Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors | Human Necessities | 2 | Active |
| US11999730B1 | AKT1 modulators | Chemistry; Metallurgy | 1 | Active |
| US11345681B1 | Inhibitors of fibroblast growth factor receptor kinases | Chemistry; Metallurgy | 1 | Active |
| US9260417B2 | Therapeutic methods and compositions involving allosteric kinase inhibition | Chemistry; Metallurgy | 0 | Active |
| US11918587B2 | Treatment of cancer with a RAF inhibitor | Human Necessities | 0 | Active |
| US11358958B2 | Inhibitors of cyclin-dependent kinases | General | 0 | Revoked |
| US11390618B2 | Inhibitors of cyclin-dependent kinases | Chemistry; Metallurgy | 0 | Active |
| US6673579B2 | Methods and compositions for multiplex amplification of nucleic acids | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12209087B2 | AKT1 modulators | Chemistry; Metallurgy | 0 | Active |
| US10214513B2 | Heterocyclic compounds useful for kinase inhibition | Chemistry; Metallurgy | 0 | Active |
| US12331039B2 | Inhibitors of fibroblast growth factor receptor kinases | Chemistry; Metallurgy | 0 | Active |
| US11447493B2 | Inhibitors of cyclin-dependent kinases | Chemistry; Metallurgy | 0 | Active |
| US7053206B2 | Methods and compositions for multiplex amplification of nucleic acids | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12312336B2 | Inhibitors of RAF kinases | Chemistry; Metallurgy | 0 | Active |
| US11746095B2 | Inhibtors of RAF kinases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.